Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Ameriprise Financial Inc.

Ameriprise Financial Inc. lessened its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 52.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 116,007 shares of the company's stock after selling 129,220 shares during the quarter. Ameriprise Financial Inc. owned about 0.23% of Prestige Consumer Healthcare worth $9,059,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Avior Wealth Management LLC lifted its position in shares of Prestige Consumer Healthcare by 1,570.7% during the 4th quarter. Avior Wealth Management LLC now owns 8,554 shares of the company's stock worth $668,000 after buying an additional 8,042 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Prestige Consumer Healthcare by 5.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company's stock worth $49,667,000 after buying an additional 33,844 shares during the last quarter. Norges Bank purchased a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth approximately $40,009,000. Barclays PLC lifted its position in shares of Prestige Consumer Healthcare by 346.3% during the 3rd quarter. Barclays PLC now owns 92,444 shares of the company's stock worth $6,665,000 after buying an additional 71,730 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its position in Prestige Consumer Healthcare by 171.6% in the 4th quarter. Assenagon Asset Management S.A. now owns 46,931 shares of the company's stock valued at $3,665,000 after purchasing an additional 29,649 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

Insider Activity

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the firm's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the transaction, the senior vice president now directly owns 17,157 shares in the company, valued at approximately $1,544,130. This trade represents a 8.91% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

PBH has been the subject of a number of recent research reports. Oppenheimer increased their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research note on Thursday, February 13th. Royal Bank of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. DA Davidson increased their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, May 17th. Finally, Canaccord Genuity Group increased their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Stock Performance

Shares of PBH stock traded up $0.97 during mid-day trading on Friday, hitting $85.98. The stock had a trading volume of 341,432 shares, compared to its average volume of 297,874. Prestige Consumer Healthcare Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $90.04. The firm has a market cap of $4.25 billion, a PE ratio of 20.14, a PEG ratio of 2.69 and a beta of 0.44. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. The company's 50-day simple moving average is $83.52 and its 200-day simple moving average is $82.28.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.30 by $0.02. The business had revenue of $296.52 million during the quarter, compared to the consensus estimate of $289.36 million. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. The business's revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.02 EPS. Sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.